News

Search:
 Search

Latest News | 8 February 2013

US Regulators Seek Comment on WHO Proposal to Restrict Narcolepsy Drug Ingredient

0 Likes

The US Food and Drug Administration (FDA) has announced that it is collecting comments from industry in advance of a March 2013 meeting that will decide whether gamma-Hydroxybutyric acid (GHB), an Read More...


Latest News Regulatory Update | 12 November 2012

Brazilian, Global Regulators Focus on Pharmacovigilance

0 Likes

Together with the World Health Organization (WHO) and the Pan American Health Organization (PAHO), Brazil's National Health Surveillance Agency (Anvisa) recently hosted two international meetings on Read More...


News Latest News | 28 August 2012

South Africa Area Continues Use of Controversial Circumcision Tool

0 Likes

An advocacy group wants to know why a South African provincehealth department is continuing to use a male circumcision clamp not approvedby the World Health Organization (WHO).A report in The NewAge Read More...


Latest News | 23 July 2012

WHO Issues Guidance on PrEP Products to Minimize HIV Transmission

0 Likes

New guidance issued by the World Health Organization (WHO) is intended to aid countries in assessing pre-exposure prophylaxis (PrEP) drugs for use in preventing the transmission of HIV in high-risk Read More...


Regulatory Update | 21 May 2012

World: Regulatory Agencies Attend WHO Seminar

0 Likes

Numerous regulatory agencies met on 18 May in Geneva, Switzerland to discuss whether it is possible to find new ways to allow their drug regulatory bodies to cooperate.The meeting, an international Read More...


Latest News | 15 May 2012

New FDA Program Aims to Develop New Approaches to Clinical Trials, Pharmacovigilance

1 Likes

A new program announced by the US Food and Drug Administration aims to strengthen global regulatory capacity by working with the World Health Organization (WHO) to support new, innovative approaches Read More...


Latest News | 15 May 2012

Researchers Gauge Effects of Regulatory Systems on Counterfeit Medicines

1 Likes

A new paper exploring counterfeit and substandard medicines shows the presence of even a minimally-developed regulatory program can have a profound impact on ensuring consumers have access to genuine, Read More...


Latest News | 12 April 2012

After Flu Concerns, Regulators Look to Issue Guidelines on 'Dual Use' Preclinical Studies

0 Likes

International healthcare bodies are looking to issue guidelines on ‘dual use’ research on potentially hazardous materials and diseases after a researcher sent shockwaves through the medical community Read More...


Latest News | 4 April 2012

Global API Inspection Scheme Continues to Ramp Up, Calls for Additional Members

1 Likes

An active pharmaceutical ingredient (API) inspection program involving many of the world’s premiere global regulatory bodies announced recently its intent to standardize the inspection schemes of the Read More...


Latest News | 3 April 2012

New Initiative Aims to Harmonize Africa's Regulations

0 Likes

A new United Nations-backed initiative aims to give Africans consistent access to “essential, high quality, safe and affordable medicines” through the establishment of regulatory harmonization and Read More...


1 2
RF Today is Regulatory Focus' daily news brief. Each edition contains the top global regulatory news stories about pharmaceuticals, medical devices, biotechnology and more. Learn more

New Regulatory Focus Apps for iPad and iPhone